What is Tietze's disease?

What is Tietze's Disease?

Tietze's disease (also called Tietze syndrome) is a benign, self-limited inflammatory condition characterized by painful swelling of the costochondral, sternoclavicular, or costosternal joints, most commonly affecting the second and third ribs unilaterally. 1

Defining Clinical Features

The hallmark that distinguishes Tietze syndrome from simple costochondritis is the presence of localized swelling (tumefaction) at the affected joint, which is absent in costochondritis. 1 The condition typically presents with:

• Painful, visible swelling at one or more anterior chest wall joints (costochondral, sternoclavicular, or costosternal) 2, 3
• Unilateral presentation in most cases 1
• Sharp, stabbing pain that worsens with inspiration or palpation 1
• Reproducible tenderness on physical examination of the affected joint 2

Pathophysiology and Natural History

Tietze syndrome is a benign, non-purulent arthropathy that follows a self-limited course, typically resolving within weeks to months. 1, 2 However, symptoms can persist beyond 6 months in 55.4% of patients, making it potentially chronic despite its benign nature. 1

The condition affects all ages, sexes, and races equally, with no specific demographic predisposition. 4

Critical Diagnostic Considerations

Must Rule Out Life-Threatening Causes First

Before confirming Tietze syndrome, you must exclude cardiac and other serious etiologies, particularly in patients >35 years or with cardiac risk factors:

• Obtain ECG within 10 minutes to exclude acute coronary syndrome, aortic dissection, pulmonary embolism, or esophageal rupture 1
• Note that 7% of patients with reproducible chest wall tenderness on palpation were ultimately diagnosed with acute coronary syndrome in one study, so reproducible tenderness does not completely exclude cardiac disease 5
• Do not use nitroglycerin response as a diagnostic criterion, as relief does not distinguish cardiac from non-cardiac chest pain 1

Diagnostic Workup

• Physical examination showing increased palpation tenderness and visible swelling at the affected joint is the cornerstone of diagnosis 2
• Laboratory tests may show elevated inflammatory markers 2
• Imaging studies (ultrasound, MRI, or CT) can confirm the diagnosis and exclude other pathology 2
• Bone scintigraphy demonstrates 100% sensitivity for detecting sternoclavicular joint inflammation in patients with anterior chest wall pain 6

Important Differential Diagnoses

Tietze syndrome must be distinguished from several conditions:

• Simple costochondritis: lacks the characteristic swelling present in Tietze syndrome 1
• Primary chest wall tumors: can mimic Tietze syndrome, and CT shows higher sensitivity and specificity for differentiating tumors from Tietze syndrome 6, 7
• SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis): a chronic relapsing condition often involving sternoclavicular joints 6
• Spondyloarthritis: anterior chest wall pain affects a significant percentage of patients with axial spondyloarthritis and may be the first manifestation 6

Critical pitfall: In patients with increasing swelling size during follow-up, early diagnostic biopsy should be considered to exclude primary chest wall tumors, as 13 of 27 patients (48%) with doubling swelling size in one series were ultimately diagnosed with chest wall tumors (5 malignant, 8 benign). 7

Treatment Approach

First-Line Management (Weeks 0-2)

Maximum-dose NSAIDs are the cornerstone of initial therapy, continued for 1-2 weeks when pleuritic-type pain or inflammatory component is present. 1

Adjunctive measures include:

• Local heat or ice packs applied to the affected area 1
• Topical analgesics like lidocaine patches for localized pain relief 1
• Acetaminophen as an alternative if NSAIDs are contraindicated 1

Second-Line Options (Weeks 2-4)

If symptoms persist despite adequate NSAID therapy:

• Add low-dose colchicine to the regimen 1, 8
• Consider NSAID rotation if initial agent ineffective 1
• Short courses of oral prednisolone may be used as bridging therapy, but avoid long-term glucocorticoid use 1
• Intra-articular glucocorticoid injections can be considered while awaiting effect of other agents 1

Refractory Cases

• Re-evaluate at 12 weeks: if sustained response occurs, consider tapering to on-demand treatment 1
• Physiotherapy consultation should be part of comprehensive management 1
• Surgical resection of involved cartilage and adjacent rib may be considered in severe, medically refractory cases that are resistant to conservative therapies, though this is not typical treatment 3

Follow-Up Monitoring

Reassess patients with persistent pain to rule out other potential causes including chronic non-bacterial osteitis, SAPHO syndrome, or axial spondyloarthritis. 1 Patients with increasing swelling size require particularly close follow-up and consideration of biopsy to exclude malignancy. 7